Peripheral Blood Stem Cell TransplantationBone MarrowHematopoietic Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell MobilizationBone Marrow TransplantationBone Marrow CellsGranulocyte Colony-Stimulating FactorLeukapheresisHematopoietic Stem CellsTransplantation, HomologousStem CellsBlood Component RemovalAntigens, CD34Transplantation ConditioningHematologic NeoplasmsGraft vs Host DiseaseMelphalanCyclophosphamideCombined Modality TherapyGraft SurvivalBone and BonesBone Marrow DiseasesMultiple MyelomaStem Cell TransplantationBlood CellsBusulfanHematopoiesisAntineoplastic Combined Chemotherapy ProtocolsBlood Cell CountBone Marrow PurgingTreatment OutcomeCord Blood Stem Cell TransplantationLymphoma, Non-HodgkinTissue DonorsEtoposideWhole-Body IrradiationTransplantation ChimeraAntineoplastic Agents, AlkylatingRecurrenceMyeloablative AgonistsLeukemiaThiotepaColony-Forming Units AssayRemission InductionHistocompatibilityCell DifferentiationFlow CytometryBone Marrow ExaminationCell SeparationAnemia, AplasticTime FactorsHistocompatibility TestingPlatelet CountCells, CulturedBone Marrow NeoplasmsImmunophenotypingIfosfamideLeukemia, Myeloid, AcuteBlood DonorsLeukocyte CountCytarabineDisease-Free SurvivalEmbryonic Stem CellsRecombinant ProteinsTransplantation, IsogeneicRetrospective StudiesLeukocytes, MononuclearInfectionLymphomaNeoplasmsAdult Stem CellsImmunosuppressive AgentsVidarabineSurvival RateAntigens, CDVincristineHodgkin DiseaseBone RemodelingT-LymphocytesStem Cell FactorSalvage TherapyPOEMS SyndromeMyelodysplastic SyndromesImmunomagnetic SeparationGranulocytesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveSurvival AnalysisHematologic DiseasesMice, Inbred C57BLCarmustineLymphocyte DepletionGranulocyte-Macrophage Colony-Stimulating FactorCell CountPlatelet TransfusionBone NeoplasmsLeukocyte TransfusionProchlorperazineCell LineageDoxorubicin